Eight cases of primary duodenal carcinoma in a district general hospital are presented. The cases highlight the advanced state of the disease at presentation, the difficulty in diagnosis, and its poor prognosis. Duodenal carcinoma occurs in both sexes worldwide with no predisposing factors in the majority of cases. There is an increased risk in patients with familial adenomatous polyposis and adenomas of the duodenum. Duodenal carcinoma occurs about 22 years from the diagnosis of familial adenomatous polyposis in about 2% of patients, forming over 50% of upper gastrointestinal cancers occurring in these patients. Carcinomatous changes occur in 30 to 60% of duodenal villous adenomas and much less in tubulo-villous and tubular adenomas. These categories of patients should be screened and adequately followed up.
Summary
Eight cases of primary duodenal carcinoma in a district general hospital are presented. The cases highlight the advanced state of the disease at presentation, the difficulty in diagnosis, and its poor prognosis. Duodenal carcinoma occurs in both sexes worldwide with no predisposing factors in the majority of cases. There is an increased risk in patients with familial adenomatous polyposis and adenomas of the duodenum. Duodenal carcinoma occurs about 22 years from the diagnosis of familial adenomatous polyposis in about 2% of patients, forming over 50% of upper gastrointestinal cancers occurring in these patients. Carcinomatous changes occur in 30 to 60% of duodenal villous adenomas and much less in tubulo-villous and tubular adenomas. These categories of patients should be screened and adequately followed up.
Aggressive and radical surgery, even in the presence of locally advanced disease and lymph node involvement, gives a better outcome. When curative surgery is not possible, chemotherapy must accompany palliation with or without radiotherapy. Pre-operative chemotherapy may facilitate a curative radical resection. The general five-year survival is 17-33% but some centres have achieved a five-year survival of40-60% with aggressive management of these patients. Keywords : duodenal carcinoma, predisposing factors, treatment Primary duodenal carcinoma is rare, but it is the commonest duodenal malignancy.1 It forms 60-100% of all duodenal malignancies and between 11 and 24% of all small bowel malig- [2] [3] [4] [5] [6] [7] nancies. -In England and Wales in 1987, small bowel malignancies (including duodenal) were 0.93% ofall bowel cancers registered with a rate of 0.7 per 100 000 ofpopulation.8 Presentation is late, diagnosis is often difficult and despite improved survival from some centres, prognosis is still poor. Because of their rarity, duodenal carcinomas are reported in the literature as case reports or a collection of few cases; management therefore varies from one hospital to another. We present eight cases diagnosed in the Pathology Department of a district general hospital over a five-year period and review the current literature.
Patients and result
The clinical and pathological records of eight patients with duodenal carcinoma were reviewed retrospectively. The patients were diagnosed between June 1988 and June 1993 in the Pathology Department of Kings Mill Hospital, Sutton-in-Ashfield, Nottinghamshire. There were six females and two men with a median age of 63.5 years (range . Six patients presented with abdominal pain, four with intestinal bleeding (two acute and two chronic) and three with weight loss. Two patients had duodenal obstruction and jaundice and another had a change in bowel habit. Both patients with jaundice had direct invasion of the pancreatic head. Median time of presentation after the onset of symptoms varied from one day to two years (median 3.5 months).
Seven patients had upper gastrointestinal endoscopy, five of whom had biopsies and duodenal carcinoma diagnosed. The two patients without biopsy had peptic ulcer diagnosed and both needed a second endoscopy, only one had a biopsy and a correct diagnosis. The other patient, diagnosed at laparatomy, had a previous barium meal which showed duodenal obstruction due to a post peptic ulcer benign stricture. The other patient not to have an initial biopsy had a barium meal; this showed an apple core lesion in the third part of the duodenum. The only patient not investigated with endoscopy had a barium meal and active duodenal ulcer diagnosed. One patient had computed tomography (CT) scanningthis revealed a duodenal mass with nodal involvement -before being subjected to endoscopy. Six patients had a correct pre-operative diagnosis made, and in five this was within a month of presentation.
One patient had segmental resection, three had palliative duodenal bypass and one each had biliary stenting and Whipple's procedure. Two patients had no procedures because of the extent of the disease. The patient who had Whipple's procedure had a direct invasion of the pancreatic head and lymph node infiltration; he survived for 18 months. The patient who had segmental resection had infiltration of the subserosal adipose tissue but no lymph node involvement. He developed a recurrence 18 months later with lymph node involvement, diagnosed on CT scan. He was treated with chemotherapy but died six months later. Another patient had adjuvant chemotherapy with 5-fluorouracil but survived for only five months.
Six patients had peritoneal and visceral metastasis and two had local invasion. Seven patients had lymph node involvement at presentation. There were one well-differentiated, three moderately differentiated and four poorly differentiated tumours. Median survival time was six months (one to 24) with three patients (38%) surviving for one year. There is no evidence of an increase incidence of duodenal carcinoma. Analysis of 11 500 autopsy specimens over 60 years ago, yielded 0.05°% of duodenal carcinoma20 and this is similar to figures of 0.019 to 0.5% quoted in reviewsl"9 40 years later. In England and Wales, the reported incidence of small bowel tumours including duodenal carcinomas has remained constant at 0.7 per 100 000 over the past 
Conclusion
The prognosis of duodenal carcinoma is generally poor but there are encouraging reports from some centres that it is improving. Duodenal carcinoma is a slow-growing tumour; at presentation therefore, treatment should be aggressive and radical, even in the presence of locally advanced disease and lymph node involvement. Palliative surgery as a first line of treatment can be reduced to a minimum and in these patients chemotherapy with or without radiotherapy should be used. The role of adjuvant chemotherapy in patients undergoing a primary curative surgery needs to be investigated further in a multicentre trial. Available literature suggests that some patients with locally advanced disease can have their tumours debulked with chemotherapy and then offered a primary curative surgery. Patients with familial adenomatous polyposis need screening for duodenal carcinoma and all patients with adenomas of the duodenum should have these excised and should be followed up. Finally, patients with chronic anaemia with a normal large bowel and stomach should have all parts of the duodenum visualised by endoscopy and, if necessary, barium meal or hypotonic duodenography should be done.
